Buprenorphine maintenance treatment for opioid use disorder Vignette: Will is a 35-year-old male with a severe opioid use disorder (OUD). He reports smoking ¼ g of fentanyl per day for more than four years, and has...
This TI Best Evidence Webinar is offered as a companion to Therapeutics Letter 163 (September-October 2026): Buprenorphine maintenance treatment for opioid use disorder. Dr. Paxton Bach, Co-Medical Director for the BC Centre for Substance Use,...
Jump to: Program | Speakers | Accreditation SAVE THE DATES - REGISTRATION OPENS SOON! The TI Annual Course will be offered virtually on Friday, January 29 and Saturday, January 30, 2027. Tackling common and new drug therapy...
Authors: Kiarash Nikkah, Aaron M Tejani, Thomas Perry, Douglas M Salzwedel, Dionzie Ong, Simroop Ladhar, Mrinmayi Thorat. Published: 2 September 2025. https://ebm.bmj.com/content/30/Suppl_1/A54.2 Objectives The primary objective of this focused literature review was to determine whether clinically significant differences exist...